Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $11.70 $16.59 Friday, 10th May 2024 NVCR stock ended at $16.47. This is 2.11% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.56% from a day low at $16.02 to a day high of $16.59.
90 days $11.70 $18.04
52 weeks $10.87 $83.60

Historical NovoCure Limited prices

Date Open High Low Close Volume
Mar 21, 2016 $12.44 $12.74 $12.30 $12.62 151 000
Mar 18, 2016 $12.84 $13.02 $12.43 $12.45 182 300
Mar 17, 2016 $11.80 $12.97 $11.74 $12.75 189 500
Mar 16, 2016 $12.34 $12.46 $11.79 $11.99 236 600
Mar 15, 2016 $12.77 $12.77 $12.07 $12.31 293 600
Mar 14, 2016 $13.92 $13.98 $12.67 $12.82 323 600
Mar 11, 2016 $14.09 $14.88 $13.60 $13.75 211 200
Mar 10, 2016 $14.34 $14.85 $13.88 $13.91 207 900
Mar 09, 2016 $16.02 $16.37 $14.00 $14.34 297 100
Mar 08, 2016 $17.18 $17.88 $15.38 $16.06 279 800
Mar 07, 2016 $18.06 $18.72 $16.90 $17.40 418 800
Mar 04, 2016 $16.10 $18.37 $16.10 $16.55 666 800
Mar 03, 2016 $15.04 $16.06 $14.61 $16.03 537 700
Mar 02, 2016 $12.38 $15.43 $12.36 $14.58 357 800
Mar 01, 2016 $11.70 $12.69 $11.65 $12.35 381 700
Feb 29, 2016 $11.14 $12.00 $11.14 $11.69 313 900
Feb 26, 2016 $10.77 $11.31 $10.50 $11.17 269 100
Feb 25, 2016 $11.57 $11.74 $10.64 $10.80 276 900
Feb 24, 2016 $11.84 $11.93 $11.26 $11.46 153 800
Feb 23, 2016 $12.02 $12.36 $11.67 $11.82 155 500
Feb 22, 2016 $12.16 $12.38 $11.99 $12.01 190 400
Feb 19, 2016 $12.25 $12.30 $11.61 $11.78 161 100
Feb 18, 2016 $12.62 $12.94 $11.85 $12.22 226 400
Feb 17, 2016 $12.42 $12.96 $12.17 $12.56 234 000
Feb 16, 2016 $12.31 $13.08 $12.15 $12.23 208 200
Click to get the best stock tips daily for free!

About NovoCure Limited

NovoCure Limited NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c... NVCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT